S&P 500

5.631,22

0,28%

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

DCTH

Delcath Systems (DCTH)

Delcath Systems Inc

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:DCTH

<< Previous 3 4 5 6 7 8 9 10 11 12 13

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
31/08/2009	12h30	PR Newswire (US)	FDA Grants Delcath Orphan-Drug Designation for Doxorubicin	NASDAQ:DCTH
25/08/2009	12h30	PR Newswire (US)	Delcath Systems, Inc. Announces Patient Recruitment Exceeds 90%	NASDAQ:DCTH
10/08/2009	21h00	PR Newswire (US)	Delcath Systems to Present at Canaccord Adams 29th Annual Global Growth Conference	NASDAQ:DCTH
28/07/2009	00h16	PR Newswire (US)	Delcath Systems Provides Update on Progress	NASDAQ:DCTH
27/07/2009	22h05	PR Newswire (US)	Delcath Systems Provides Update on Progress	NASDAQ:DCTH
14/07/2009	12h30	PR Newswire (US)	Delcath Systems to Host July 27th Conference Call to Update Investors on Recent Progress	NASDAQ:DCTH
06/07/2009	14h11	PR Newswire (US)	Eamonn Hobbs Appointed President & CEO of Delcath Systems, Inc.	NASDAQ:DCTH
15/06/2009	14h00	PR Newswire (US)	Delcath Systems Receives Preliminary Notification of Inclusion in Russell 3000(R) Index	NASDAQ:DCTH
10/06/2009	14h00	PR Newswire (US)	Delcath Enters Agreement to Sell 869,565 Units	NASDAQ:DCTH
08/06/2009	14h00	PR Newswire (US)	Enrollment in Delcath's Pivotal Phase III Metastatic Melanoma Clinical Trial Achieves Seventy-Five Percent Accrual	NASDAQ:DCTH
02/06/2009	14h00	PR Newswire (US)	Delcath Systems Granted Third Orphan Drug Designation	NASDAQ:DCTH
07/05/2009	16h43	PR Newswire (US)	Eric D. Whitman, MD to Present on the Delcath PHP System(TM) at the 7th World Congress on Melanoma	NASDAQ:DCTH
09/04/2009	15h04	PR Newswire (US)	Delcath Continues Expansion of Clinical Trial Centers Offering PHP(TM)	NASDAQ:DCTH
19/02/2009	14h24	PR Newswire (US)	Dr. James F. Pingpank to Present at Leading Regional Therapies Conference	NASDAQ:DCTH
20/01/2009	19h44	PR Newswire (US)	Delcath Systems to Host Quarterly Update Conference Call	NASDAQ:DCTH
30/12/2008	16h26	PR Newswire (US)	Delcath Systems to Host Quarterly Update Conference Call	NASDAQ:DCTH
17/12/2008	14h00	PR Newswire (US)	Delcath Adds Dr. Pamela R. Contag to Its Board of Directors	NASDAQ:DCTH
11/12/2008	14h00	PR Newswire (US)	Enrollment in Delcath's Pivotal Phase III Metastatic Melanoma Clinical Trial Reaches Halfway Point	NASDAQ:DCTH
09/12/2008	14h00	PR Newswire (US)	Delcath Adds Senior Pharmaceutical Professional to Its Board of Directors	NASDAQ:DCTH
04/12/2008	14h00	PR Newswire (US)	Jonathan Lewis, M.D., Ph.D. Steps Down From Delcath Systems Board of Directors	NASDAQ:DCTH
02/12/2008	14h00	PR Newswire (US)	Delcath Adds University of Pittsburgh Medical Center to Phase III Trial	NASDAQ:DCTH
18/11/2008	14h00	PR Newswire (US)	Delcath Systems Granted Orphan-Drug Designations for Cutaneous and Ocular Melanoma	NASDAQ:DCTH